Application of Telemedicine for Dermatological Emergency Patients

Dermatological Emergency Clinical Trial

— Telederm  

Official title:

Application of Telemedicine for Dermatological Emergency Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02836665
• Other study ID #: 16-033
• Status: Completed
• Phase: N/A
• Start date: August 2016
• Est. completion date: December 31, 2017

Study information

• Verified date: August 2018
• Source: RWTH Aachen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

After admission to the emergency room each dermatological patient is routinely assessed to Manchester Triage System (MTS) by the nursing staff. Thereby data are collected for anamnesis followed by randomization in two equal study groups.

Patients of group A (control group) wait routinely until the dermatological investigator in charge arrives at the emergency room. Once the dermatological investigator is on site, he gives a diagnosis and proposes a therapy.

For Patients of group B (teledermatology) study-related photographs of the skin lesion and anamnesis data are uploaded to the hospital information system "medico". Those data can directly be processed by the dermatological investigator in charge who enters his diagnosis and his therapy proposal.

Subsequently an internal control is carried out as the same investigator comes personally to the emergency room to check its telemedical diagnosis and therapy proposal.

Finally both time periods patients have to wait in the emergency room for their diagnosis and therapy are compared with each other.

Description:

After admission to the emergency room each dermatological patient is routinely assessed to Manchester Triage System (MTS) by the nursing staff. Thereby data are collected for anamnesis (duration of symptoms, allergies, self-medication, medical history) followed by randomization in two equal study groups.

Patients of group A (control group) wait routinely until the dermatological investigator in charge arrives at the emergency room. Once the dermatological investigator is on site, he gives a diagnosis and proposes a therapy.

Time is measured from the patients admission to the emergency room up to the personnel diagnosis and therapy by the dermatological investigator in charge.

For Patients of group B (teledermatology) first of all study-related photographs of the skin lesions are taken with a tablet. After that the registration of the consult "teledermatology" is carried out by the emergency investigator in charge, who uploads the photographs as well as the data for anamnesis to the hospital information system "medico". The consult "teledermatology" can directly be processed by the dermatological investigator in charge who enters his diagnosis and his therapy proposal.

Time is measured from admission to the emergency room up to the telemedical diagnosis and therapy by the dermatological investigator in charge.

Subsequently an internal control is carried out as the same investigator comes personally to the emergency room to check its telemedical diagnosis and therapy proposal.

Finally both time measurements are compared with each other.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 31, 2017
• Est. primary completion date: July 14, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male or female aged = 18 years

• Written informed consent prior to study participation

• Adults who are contractually capable and mentally able to understand and follow the instructions of the study personnel.

• Dermatological emergency patient

Exclusion Criteria:

• Male or female aged < 18 years

• Missing informed consent prior to study participation

• Patient has been committed to an institution by legal or regulatory order

• Persons in dependence from the sponsor or working with the sponsor

• Participation in another clinical trial within the previous 2 months

Related Conditions & MeSH terms

• Dermatological Emergency
• Emergencies

Intervention

Procedure:
• Telemedicine for dermatological emergency patients
Study-related photographs of the skin lesion made by a tablet and anamnesis data are uploaded to the hospital information system "medico". Those data can directly be processed by the dermatological investigator in charge who enters his diagnosis and his therapy proposal without being on site.

Locations

Country	Name	City	State
Germany	Uniklinik RWTH Aachen	Aachen

Sponsors (1)

Lead Sponsor	Collaborator
RWTH Aachen University

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Marsden J, Windle J, Mackway-Jones K. Emergency triage. Emerg Nurse. 2013 Jul;21(4):11. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Waiting time [min]	Time is measured from the patients admission to the emergency room up to the personnel/telemedical diagnosis and therapy by the dermatological investigator in charge.	1 emergency visit [approximately 2 hours]
Secondary	Number of differences between the personally and the telemedical diagnosis and therapy proposal	An internal control is carried out as the same investigator comes personally to the emergency room to check its telemedical diagnosis and therapy proposal.	1 emergency visit [approximately 2 hours]